Angiogenesis considerations: BPC-157 works by promoting the formation of new blood vessels, so individuals with active cancer or a cancer history should use extra caution and involve their oncology team
Among its various actions, GLP-1 stimulates glucose-dependent insulin secretion, inhibits glucagon secretion, delays gastric emptying, enhances feelings of satiety, and consequently reduces food intake [10,11,12]
Most of the weight loss occurs in the first 6 months, with the remaining months showing smaller incremental reductions
Tirzepatide's dual GLP-1/GIP mechanism activates an additional appetite-suppression pathway, often producing results for patients who plateaued on semaglutide
manufacturer savings cards can reduce costs to as little as $25/month for eligible commercially insured patients
Ni recommends lifestyle changes like diet and exercise first